Literature DB >> 14661934

PLGA/TPGS nanoparticles for controlled release of paclitaxel: effects of the emulsifier and drug loading ratio.

Li Mu1, Si-Shen Feng.   

Abstract

PURPOSE: We successfully manufactured nanoparticles of biodegradable polymers for controlled release of paclitaxel. TPGS (d-alpha-tocopheryl polyethylene glycol 1000 succinate) could be a novel material to make nanoparticles of high drug encapsulation efficiency (EE) and desired physicochemical and pharmaceutical properties of the drug loaded nanoparticles. Among various controlling parameters in the process, the present work is to elucidate the effects of the surfactant stabilizer and the drug loading ratio.
METHODS: Paclitaxel loaded PLGA nanoparticles were formulated at various drug-loading ratios by a modified single emulsion solvent extraction/evaporation technique. TPGS was introduced either as the emulsifier or as a matrix material component by using different technique. Polyvinyl alcohol (PVA) was also used for a comparison. The nanoparticles of various recipes were characterized by various state-of-the-art instrument technology for their properties.
RESULTS: The EE and the in vitro release behavior were found significantly influenced by the drug loading ratio and the surfactant stabilizer encountered. TPGS involved nanoparticles can have high EE and other favorable properties.
CONCLUSIONS: TPGS could be a novel and effective emulsifier, which can result in high EE and desired properties of paclitaxel-loaded polymeric nanoparticles.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14661934     DOI: 10.1023/b:pham.0000003387.15428.42

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  17 in total

Review 1.  Biodegradable polymeric nanoparticles as drug delivery devices.

Authors:  K S Soppimath; T M Aminabhavi; A R Kulkarni; W E Rudzinski
Journal:  J Control Release       Date:  2001-01-29       Impact factor: 9.776

2.  Lidocaine-loaded biodegradable nanospheres. I. Optimization Of the drug incorporation into the polymer matrix.

Authors:  T Görner; R Gref; D Michenot; F Sommer; M N Tran; E Dellacherie
Journal:  J Control Release       Date:  1999-02-22       Impact factor: 9.776

3.  Preparation of poly(DL-lactide-co-glycolide) nanoparticles by modified spontaneous emulsification solvent diffusion method.

Authors:  H Murakami; M Kobayashi; H Takeuchi; Y Kawashima
Journal:  Int J Pharm       Date:  1999-10-05       Impact factor: 5.875

4.  Effects of cyclosporin and cremophor on working rat heart and incidence of myocardial lipid peroxidation.

Authors:  E Tatou; C Mossiat; V Maupoil; F Gabrielle; M David; L Rochette
Journal:  Pharmacology       Date:  1996-01       Impact factor: 2.547

5.  Is Cremophor EL, solvent for paclitaxel, cytotoxic?

Authors:  M L Fjällskog; L Frii; J Bergh
Journal:  Lancet       Date:  1993-10-02       Impact factor: 79.321

6.  Quantitative analysis of polyvinyl alcohol on the surface of poly(D, L-lactide-co-glycolide) microparticles prepared by solvent evaporation method: effect of particle size and PVA concentration.

Authors:  S C Lee; J T Oh; M H Jang; S I Chung
Journal:  J Control Release       Date:  1999-05-20       Impact factor: 9.776

Review 7.  Paclitaxel and its formulations.

Authors:  Anil K Singla; Alka Garg; Deepika Aggarwal
Journal:  Int J Pharm       Date:  2002-03-20       Impact factor: 5.875

8.  Influence of experimental parameters on the characteristics of poly(lactic acid) nanoparticles prepared by a double emulsion method.

Authors:  M F Zambaux; F Bonneaux; R Gref; P Maincent; E Dellacherie; M J Alonso; P Labrude; C Vigneron
Journal:  J Control Release       Date:  1998-01-02       Impact factor: 9.776

9.  A novel controlled release formulation for the anticancer drug paclitaxel (Taxol): PLGA nanoparticles containing vitamin E TPGS.

Authors:  L Mu; S S Feng
Journal:  J Control Release       Date:  2003-01-09       Impact factor: 9.776

10.  Cancer research. Nanoparticles cut tumors' supply lines.

Authors:  Jennifer Couzin
Journal:  Science       Date:  2002-06-28       Impact factor: 47.728

View more
  47 in total

1.  Chitosan film containing poly(D,L-lactic-co-glycolic acid) nanoparticles: a platform for localized dual-drug release.

Authors:  Dayane B Tada; Surinder Singh; Dattatri Nagesha; Evan Jost; Craig O Levy; Evin Gultepe; Robert Cormack; G Mike Makrigiorgos; Srinivas Sridhar
Journal:  Pharm Res       Date:  2010-06-03       Impact factor: 4.200

2.  Oral administration of pH-sensitive curcumin-loaded microparticles for ulcerative colitis therapy.

Authors:  Bo Xiao; Xiaoying Si; Mingzhen Zhang; Didier Merlin
Journal:  Colloids Surf B Biointerfaces       Date:  2015-08-01       Impact factor: 5.268

3.  Protein adsorption and cellular uptake of cerium oxide nanoparticles as a function of zeta potential.

Authors:  Swanand Patil; Amanda Sandberg; Eric Heckert; William Self; Sudipta Seal
Journal:  Biomaterials       Date:  2007-08-01       Impact factor: 12.479

4.  Orally Targeted Delivery of Tripeptide KPV via Hyaluronic Acid-Functionalized Nanoparticles Efficiently Alleviates Ulcerative Colitis.

Authors:  Bo Xiao; Zhigang Xu; Emilie Viennois; Yuchen Zhang; Zhan Zhang; Mingzhen Zhang; Moon Kwon Han; Yuejun Kang; Didier Merlin
Journal:  Mol Ther       Date:  2017-01-28       Impact factor: 11.454

5.  Oral delivery of curcumin via porous polymeric nanoparticles for effective ulcerative colitis therapy.

Authors:  Qiubing Chen; Xiaoying Si; Lijun Ma; Panpan Ma; Meili Hou; Shuang Bai; Xiaoshuai Wu; Ying Wan; Bo Xiao; Didier Merlin
Journal:  J Mater Chem B       Date:  2017-05-05       Impact factor: 6.331

6.  A covalently stabilized lipid-polycation-DNA (sLPD) vector for antisense oligonucleotide delivery.

Authors:  Xiaojuan Yang; Yong Peng; Bo Yu; Jianhua Yu; Chenguang Zhou; Yicheng Mao; L James Lee; Robert J Lee
Journal:  Mol Pharm       Date:  2011-03-23       Impact factor: 4.939

7.  Improved antifungal activity of amphotericin B-loaded TPGS-b-(PCL-ran-PGA) nanoparticles.

Authors:  Xiaolong Tang; Ronghong Jiao; Chunmei Xie; Lifa Xu; Zhen Huo; Jingjing Dai; Yunyun Qian; Weiwen Xu; Wei Hou; Jiang Wang; Yong Liang
Journal:  Int J Clin Exp Med       Date:  2015-04-15

8.  Zinc protoporphyrin polymeric nanoparticles: potent heme oxygenase inhibitor for cancer therapy.

Authors:  Hasti Rouhani; Nima Sepehri; Hamed Montazeri; Mohammad Reza Khoshayand; Mohammad Hossein Ghahremani; Seyed Nasser Ostad; Fatemeh Atyabi; Rassoul Dinarvand
Journal:  Pharm Res       Date:  2014-02-21       Impact factor: 4.200

9.  Development of high drug loaded and customizing novel nanoparticles for modulated and controlled release of Paclitaxel.

Authors:  Primiano Pio Di Mauro; Salvador Borrós
Journal:  Pharm Res       Date:  2014-06-18       Impact factor: 4.200

10.  Co-delivery of camptothecin and curcumin by cationic polymeric nanoparticles for synergistic colon cancer combination chemotherapy.

Authors:  Bo Xiao; Xiaoying Si; Moon Kwon Han; Emilie Viennois; Mingzhen Zhang; Didier Merlin
Journal:  J Mater Chem B       Date:  2015-09-01       Impact factor: 6.331

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.